metaMe Health has received FDA 510(k) clearance for Regulora, a prescription digital therapeutic aimed at treating abdominal pain associated with irritable bowel syndrome in adults.
Regulora is a smartphone app that delivers behavioral therapy based on gut-directed hypnotherapy to alleviate IBS pain.
“The FDA’s clearance of Regulora, our first PDT, is a major achievement for the company,” Tim...
Pear Therapeutics has announced a new deal with Ironwood Pharmaceuticals that will explore the platform’s potential for patients with certain gastrointestinal (GI) conditions.
“We are excited to be partnering with Ironwood on this initiative and believe there is a compelling clinical rationale for use of [prescription digital therapeutics] in treating GI diseases,” Dr. Corey McCann, president and...
Chicago-based SonarMD, which uses digital technologies to help payers improve the health of certain high-volatility patient groups, has raised $10 million in Series A funding. The raise is a joint investment between BCBS Venture Partners and Arboretum Ventures.
What they do
“What SonarMD does is we are providing care management services for what we call high beta chronic conditions,” CEO Devin...
Digital gastrointestinal health company Vivante Health has raised $6 million in Series A funding, according to an announcement. New York-based NFP Ventures and Nashville-based FCA Venture Partners participated in the round.
What they do
Headed by Livongo founder Dr. Kimon Angelides, Vivante makes a digital program for digestive health and disease called GIThrive that includes, among other tools,...
Without a medical background, listening to a doctor describe a complex procedure can feel a little bit like listening to a lecture in gibberish. That communication gap is particularly wide between pediatric patients and their doctors, but a new virtual reality technology could help facilitate conversation between doctors and patients.
Boston Children’s Hospital is teaming up with Klick Health to...
